companydata.dkcompanydata.dk
Back to company

PULMOPHARMA ApS: Financial statements 2016

CVR: 36428023

PULMOPHARMA ApS (CVR 36428023) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity amounted to DKK -2,920.

Gross Profit
0 kr.
Profit/Loss
0 kr.
Equity
-2,920 kr.
Total Assets
80 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PULMOPHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2016

PULMOPHARMA ApS publishes interim reportJun 11, 2016

PULMOPHARMA ApS has published its interim report for the period November 1, 2014 – December 31, 2015.

About PULMOPHARMA ApS

PULMOPHARMA ApS is a Danish company of the type Anpartsselskab based in Ebeltoft, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dan Mønster Nielsen. The company's owners include PETER BANG HOLDING ApS, LARS NYENSTAD ApS and BENDIX-HOLDING ApS. In 2025, the company reported a gross profit of DKK -49,353 and a net result of DKK -49,353 compared with DKK -20,499 the year before. Equity amounted to DKK 11,436,934.

Other financial years

202520242023202220212020201920182017